Accendra Health (ACH) COO receives 108,696-share restricted stock award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bernocchi Perry A reported acquisition or exercise transactions in this Form 4 filing.
Accendra Health executive Perry A. Bernocchi, EVP and Chief Operating Officer, received a grant of 108,696 shares of Common Stock as equity compensation. The restricted stock grant vests one-third per year over three years. Following this award, his directly held stake totals 342,662 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bernocchi Perry A
Role
EVP, Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 108,696 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 342,662 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Accendra Health (ACH) report for Perry A. Bernocchi?
Accendra Health reported an equity grant to Perry A. Bernocchi. He received 108,696 shares of Common Stock as a restricted stock award, recorded as an acquisition rather than an open-market purchase, reflecting part of his executive compensation package at the company.
What is the vesting schedule for Perry A. Bernocchi’s Accendra Health (ACH) restricted stock?
The restricted stock vests over three years. According to the filing footnote, the 108,696-share grant vests in equal installments, with one-third of the award vesting each year over a three-year period, subject to the grant’s ongoing vesting conditions.
Was Perry A. Bernocchi’s Accendra Health (ACH) transaction an open-market stock purchase?
No, it was not an open-market purchase. The Form 4 classifies the transaction under code A as a grant, award, or other acquisition, with a transaction price of $0.0000 per share, indicating an equity compensation grant rather than a market trade.
What does transaction code "A" mean in Perry A. Bernocchi’s Accendra Health (ACH) Form 4?
Transaction code "A" indicates a grant or award acquisition. In this case, it reflects a restricted stock grant of 108,696 shares, received as compensation, rather than a purchase or sale made by Bernocchi in the open market.